191 related articles for article (PubMed ID: 35730756)
1. The Variable Response to Teduglutide in Pediatric Short Bowel Syndrome: A Single Country Real-Life Experience.
Guz-Mark A; Hino B; Berkowitz D; Hartman C; Millman PN; Orlanski-Meyer E; Shaoul R; Spector-Cohen I; Weiss B; Zangen T; Shamir R
J Pediatr Gastroenterol Nutr; 2022 Sep; 75(3):293-298. PubMed ID: 35730756
[TBL] [Abstract][Full Text] [Related]
2. Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study.
Germán-Díaz M; Alcolea A; Cabello V; Blasco-Alonso J; Rodríguez A; Galera R; García-Romero R; Romero C; González-Sacristán R; Redecillas-Ferreiro S; Moreno-Villares JM; Ramos-Boluda E
Eur J Pediatr; 2024 Apr; ():. PubMed ID: 38664251
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.
Lambe C; Talbotec C; Kapel N; Barbot-Trystram L; Brabant S; Nader EA; Pigneur B; Payen E; Goulet O
Am J Clin Nutr; 2023 Jun; 117(6):1152-1163. PubMed ID: 37270289
[TBL] [Abstract][Full Text] [Related]
4. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
Lam K; Schwartz L; Batisti J; Iyer KR
JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
Ukleja A; To C; Alvarez A; Lara LF
JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279
[TBL] [Abstract][Full Text] [Related]
6. Cost-utility analysis of teduglutide compared to standard care in weaning parenteral nutrition support in children with short bowel syndrome.
Gattini D; Belza C; Kraus R; Avitzur Y; Ungar WJ; Wales PW
Clin Nutr; 2023 Dec; 42(12):2363-2371. PubMed ID: 37862822
[TBL] [Abstract][Full Text] [Related]
7. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
Joly F; Seguy D; Nuzzo A; Chambrier C; Beau P; Poullenot F; Thibault R; Armengol Debeir L; Layec S; Boehm V; Lallemand J; Quilliot D; Schneider SM
Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H
J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
[TBL] [Abstract][Full Text] [Related]
9. Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome.
Carter BA; Cohran VC; Cole CR; Corkins MR; Dimmitt RA; Duggan C; Hill S; Horslen S; Lim JD; Mercer DF; Merritt RJ; Nichol PF; Sigurdsson L; Teitelbaum DH; Thompson J; Vanderpool C; Vaughan JF; Li B; Youssef NN; Venick RS; Kocoshis SA
J Pediatr; 2017 Feb; 181():102-111.e5. PubMed ID: 27855998
[TBL] [Abstract][Full Text] [Related]
10. Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide-9 Years of Follow-Up.
Zaczek Z; Jurczak-Kobus P; Panczyk M; Braszczyńska-Sochacka J; Majewska K; Kunecki M; Dąbrowska K; Sobocki J
Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458196
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
[TBL] [Abstract][Full Text] [Related]
12. Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data.
Ramos Boluda E; Redecillas Ferreiro S; Manrique Moral O; García Romero R; Irastorza Terradillos I; Nuñez Ramos R; Germán Díaz M; Polo Miquel B; Vives Piñera I; Alcolea Sánchez A; González Sacristán R; Bautista Barea M; Moreno Villares JM
J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):734-739. PubMed ID: 32804906
[TBL] [Abstract][Full Text] [Related]
13. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B; O'Keefe SJ
Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170
[TBL] [Abstract][Full Text] [Related]
14. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
Jeppesen PB
JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
[TBL] [Abstract][Full Text] [Related]
16. Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support.
Chen K; Joly F; Mu F; Kelkar SS; Olivier C; Xie J; Seidner DL
Clin Nutr ESPEN; 2021 Jun; 43():420-427. PubMed ID: 34024550
[TBL] [Abstract][Full Text] [Related]
17. Teduglutide in short bowel syndrome patients: A way back to normal life?
Harpain F; Schlager L; Hütterer E; Dawoud C; Kirchnawy S; Stift J; Krotka P; Stift A
JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):300-309. PubMed ID: 34614239
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
Greif S; Maasberg S; Wehkamp J; Fusco S; Zopf Y; Herrmann HJ; Lamprecht G; Jacob T; Schiefke I; von Websky MW; Büttner J; Blüthner E; Tacke F; Pape UF
Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure.
O'Keefe SJ; Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):815-23.e1-3. PubMed ID: 23333663
[TBL] [Abstract][Full Text] [Related]
20. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
Iyer KR; Kunecki M; Boullata JI; Fujioka K; Joly F; Gabe S; Pape UF; Schneider SM; Virgili Casas MN; Ziegler TR; Li B; Youssef NN; Jeppesen PB
JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
